In China, a company named DeepSeek is using AI to develop drugs faster and cheaper than before. This surprised many people in the industry. DeepSeek's technology is said to be as good and cost much less than leading U.S. AI companies. This has caused a debate about AI companies and drug development in the U.S. DeepSeek spent less than $6 million to train its large language model, while American company OpenAI spent billions on a similar technology called ChatGPT. If you want to read more about this story, you can subscribe to STAT+ to unlock the rest of the article. Subscribe now to get more news about artificial intelligence, biotechnology, drug development, and more. Brian Yang, a reporter who covers the Chinese biopharma industry, has been following this story for over 12 years. He used to be a managing editor for Citeline's Scrip and Pink Sheet in Beijing. Overall, this story shows how technology is changing the way we develop medicine and how different countries are using AI to make advancements in drug development. Remember to stay curious and keep learning about new technologies like artificial intelligence and biotechnology!